LeMaitre Vascular logo
LMATLeMaitre Vascular
Trade LMAT now
LeMaitre Vascular primary media

About LeMaitre Vascular

LeMaitre Vascular (NASDAQ:LMAT) specializes in developing, manufacturing, and marketing medical devices for the treatment of vascular diseases. Its product portfolio includes technologies aimed at improving the effectiveness and efficiency of vascular surgery, with an emphasis on minimally invasive procedures. The company is deeply invested in ongoing research and development projects to advance vascular treatment options, aiming to enhance patient outcomes and streamline surgical practices. With a global operational footprint, LeMaitre Vascular is focused on expanding its market presence and establishing itself as a trusted partner in the vascular health sector by providing innovative solutions that address the evolving needs of healthcare professionals and their patients.

What is LMAT known for?

Snapshot

Public US
Ownership
1986
Year founded
456
Employees
Burlington, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de LeMaitre Vascular

  • XenoSure Biologic Patches are used in vascular surgery to repair blood vessels, offering an effective solution for tissue regeneration.
  • The Over-the-Wire LeMaitre Valvulotome offers precision in in-situ bypass surgeries, enhancing operational success.
  • AlboGraft Polyester Vascular Grafts are designed for arterial and aortic grafting, providing durable and reliable alternatives for various vascular surgeries.
  • The ProCol Vascular Bioprosthesis assists with hemodialysis access maintenance, significantly improving patient outcomes.
  • AnastoClip Vascular Closure System ensures secure closure of vascular sutures, minimizing leakage and promoting faster healing.
  • The TAArget Thoracic Stent Graft provides a minimally invasive solution for the treatment of thoracic aortic aneurysms, enhancing patient recovery times.

equipe executiva do LeMaitre Vascular

  • Mr. George W. LeMaitreChairman & CEO
  • Mr. David B. RobertsPresident & Director
  • Mr. Trent G. KamkeSenior Vice President of Operations
  • Dr. George D. LeMaitre FACS, M.D.Founder and Chairman of Scientific Advisory Board
  • Mr. Dorian LeBlanc CPAChief Financial Officer
  • Ms. Kimberly L. CieslakVice President of Marketing
  • Mr. Daniel J. MumfordSenior Director of Human Resources
  • Mr. Jonathan W. NgauSenior Vice President of Information Technology
  • Mr. Maik D. HelmersSenior Vice President of Sales ? Central Europe
  • Mr. Ryan H. ConnellySenior Vice President of Advanced Manufacturing Engineering

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.